Entity Type
Company
SEC filings, ownership reports, and insider transactions for CIK 0001949257.
Entity Type
Company
Total Filings
121
Latest Filing
01 May 2026
Industry
Pharmaceutical Preparations
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
6-K filed on 01 May 2026 for CIK 0001949257.
6-K filed on 01 May 2026 for CIK 0001949257.
Return Loop
A newly filed 6-K can change the filing history, ownership context, or next research path for Radiopharm Theranostics Ltd.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
Latest financial period: Q2 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
18 Sep 2025
Page type
Company facts
Latest period
Q2 2025
SEC-backed company facts were refreshed from filings filed on 18 Sep 2025.
Benchmark Context
Radiopharm Theranostics Ltd has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q2 2025. That gives you a fresh baseline before you compare this company with peers.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Radiopharm Theranostics Ltd has filed 121 SEC EDGAR filings since 16 Dec 2022. Common forms include 6-K, 3, SCHEDULE 13G/A, SCHEDULE 13G and more.
Recent SEC filings for Radiopharm Theranostics Ltd with direct links to document and filing folders.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 01 May 2026 | 01 May 2026 | 001-41621 |
| 3 | Open 3 document | View SEC filing for 3 | 30 Apr 2026 | 18 Mar 2026 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 23 Apr 2026 | 23 Apr 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Apr 2026 | 20 Apr 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 16 Apr 2026 | 16 Apr 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 08 Apr 2026 | 08 Apr 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 07 Apr 2026 | 07 Apr 2026 | 001-41621 |
| 3 | Open 3 document | View SEC filing for 3 | 01 Apr 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 01 Apr 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 31 Mar 2026 | 18 Mar 2026 | ||
| 3 | Open 3 document | View SEC filing for 3 | 31 Mar 2026 | 18 Mar 2026 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 27 Mar 2026 | 27 Mar 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 24 Mar 2026 | 24 Mar 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 19 Mar 2026 | 19 Mar 2026 | 001-41621 |
| 3 | Open 3 document | View SEC filing for 3 | 18 Mar 2026 | 18 Mar 2026 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 27 Feb 2026 | 27 Feb 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 24 Feb 2026 | 24 Feb 2026 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 28 Jan 2026 | 28 Jan 2026 | 001-41621 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 16 Jan 2026 | 005-94814 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 12 Jan 2026 | 12 Jan 2026 | 001-41621 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 08 Jan 2026 | 005-94814 | ||
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 23 Dec 2025 | 333-292198 | ||
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 23 Dec 2025 | 333-292178 | ||
| 424B3 | Open 424B3 document | View SEC filing for 424B3 | PROSPECTUS | 23 Dec 2025 | 333-292198 | |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | PROSPECTUS SUPPLEMENT | 23 Dec 2025 | 333-292178 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 19 Dec 2025 | 19 Dec 2025 | 001-41621 |
| F-3 | Open F-3 document | Open XBRL data | View SEC filing for F-3 | REGISTRATION STATEMENT | 17 Dec 2025 | 333-292198 | |
| F-3 | Open F-3 document | Open XBRL data | View SEC filing for F-3 | REGISTRATION STATEMENT | 16 Dec 2025 | 333-292178 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 15 Dec 2025 | 15 Dec 2025 | 001-41621 |
| 20-F/A | Open 20-F/A document | Open XBRL data | View SEC filing for 20-F/A | AMENDMENT NO. 1 TO FORM 20-F | 10 Dec 2025 | 30 Jun 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 04 Dec 2025 | 03 Dec 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 25 Nov 2025 | 25 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Nov 2025 | 20 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 19 Nov 2025 | 19 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 18 Nov 2025 | 18 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 17 Nov 2025 | 17 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 12 Nov 2025 | 12 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 04 Nov 2025 | 04 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 03 Nov 2025 | 03 Nov 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 28 Oct 2025 | 28 Oct 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 23 Oct 2025 | 22 Oct 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Oct 2025 | 20 Oct 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 07 Oct 2025 | 07 Oct 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 01 Oct 2025 | 01 Oct 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 30 Sep 2025 | 30 Sep 2025 | 001-41621 |
| 20-F | Open 20-F document | Open XBRL data | View SEC filing for 20-F | ANNUAL REPORT | 18 Sep 2025 | 30 Jun 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 17 Sep 2025 | 17 Sep 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 15 Sep 2025 | 15 Sep 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 29 Aug 2025 | 29 Aug 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 21 Aug 2025 | 21 Aug 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 01 Aug 2025 | 01 Aug 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 29 Jul 2025 | 29 Jul 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 28 Jul 2025 | 28 Jul 2025 | 001-41621 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 23 Jul 2025 | 005-94814 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 22 Jul 2025 | 22 Jul 2025 | 001-41621 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 16 Jul 2025 | 005-94814 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 16 Jul 2025 | 16 Jul 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 24 Jun 2025 | 24 Jun 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 12 Jun 2025 | 12 Jun 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 11 Jun 2025 | 11 Jun 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 04 Jun 2025 | 04 Jun 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 02 Jun 2025 | 02 Jun 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 30 May 2025 | 30 May 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 19 May 2025 | 19 May 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 12 May 2025 | 12 May 2025 | 001-41621 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 12 May 2025 | 005-94814 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 29 Apr 2025 | 29 Apr 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 28 Apr 2025 | 28 Apr 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 17 Mar 2025 | 17 Mar 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 13 Mar 2025 | 13 Mar 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 07 Mar 2025 | 07 Mar 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 28 Feb 2025 | 28 Feb 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 25 Feb 2025 | 25 Feb 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 24 Feb 2025 | 24 Feb 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 18 Feb 2025 | 18 Feb 2025 | 001-41621 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 11 Feb 2025 | 005-94814 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 10 Feb 2025 | 10 Feb 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 30 Jan 2025 | 30 Jan 2025 | 001-41621 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 29 Jan 2025 | 005-94814 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 21 Jan 2025 | 21 Jan 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 10 Jan 2025 | 10 Jan 2025 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 30 Dec 2024 | 30 Dec 2024 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 20 Dec 2024 | 20 Dec 2024 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 19 Dec 2024 | 19 Dec 2024 | 001-41621 |
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 18 Dec 2024 | 18 Dec 2024 | 001-41621 |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 13 Dec 2024 | 333-283627 | ||
| 424B3 | Open 424B3 document | View SEC filing for 424B3 | PROSPECTUS | 13 Dec 2024 | 333-283627 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 11 Dec 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 10 Dec 2024 | 333-283627 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 10 Dec 2024 | 10 Dec 2024 | 001-41621 |
| F-1 | Open F-1 document | View SEC filing for F-1 | REGISTRATION STATEMENT | 05 Dec 2024 | 333-283627 | |
| SEC STAFF LETTER | Open SEC STAFF LETTER document | View SEC filing for SEC STAFF LETTER | 03 Dec 2024 | |||
| F-6/A | Open F-6/A document | View SEC filing for F-6/A | 27 Nov 2024 | 333-282042 | ||
| SEC STAFF ACTION | Open SEC STAFF ACTION document | View SEC filing for SEC STAFF ACTION | 27 Nov 2024 | |||
| CERT | Open CERT document | View SEC filing for CERT | 25 Nov 2024 | 001-41621 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 25 Nov 2024 | |||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | AMENDMENT NO. 7 TO FORM 20FR12B | 12 Nov 2024 | 001-41621 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 05 Nov 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 01 Nov 2024 | 377-06505 | ||
| F-6/A | Open F-6/A document | View SEC filing for F-6/A | 25 Oct 2024 | 333-282042 | ||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | AMENDMENT NO. 6 TO FORM 20FR12B | 21 Oct 2024 | 001-41621 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 25 Sep 2024 | |||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | AMENDMENT NO. 5 TO FORM 20FR12B | 25 Sep 2024 | 001-41621 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 18 Sep 2024 | 333-282042 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 16 Sep 2024 | 377-06505 | ||
| F-6 | Open F-6 document | View SEC filing for F-6 | 11 Sep 2024 | 333-282042 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 09 Sep 2024 | |||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | AMENDMENT NO. 4 TO FORM 20FR12B | 09 Sep 2024 | 001-41621 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 22 Aug 2024 | 377-06505 | ||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | AMENDMENT NO. 3 TO FORM 20FR12B | 25 Jul 2024 | 001-41621 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 14 Apr 2023 | |||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | AMENDMENT NO. 2 TO FORM 20FR12B | 14 Apr 2023 | 001-41621 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 31 Mar 2023 | 377-06505 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 20 Mar 2023 | |||
| 20FR12B/A | Open 20FR12B/A document | View SEC filing for 20FR12B/A | AMENDMENT NO. 1 TO FORM 20FR12B | 20 Mar 2023 | 001-41621 | |
| SEC STAFF LETTER | Open SEC STAFF LETTER document | View SEC filing for SEC STAFF LETTER | 06 Mar 2023 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 01 Mar 2023 | 377-06505 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 13 Feb 2023 | |||
| 20FR12B | Open 20FR12B document | View SEC filing for 20FR12B | REGISTRATION STATEMENT | 13 Feb 2023 | 001-41621 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 13 Jan 2023 | 377-06505 | ||
| DRS | Open DRS document | View SEC filing for DRS | 16 Dec 2022 | 377-06505 |
Radiopharm Theranostics Ltd files with the SEC under CIK 0001949257. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.